• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心律失常射频导管消融术后复发及并发症的趋势和危险因素:台湾一项全国性观察性研究

Trend and risk factors of recurrence and complications after arrhythmias radiofrequency catheter ablation: a nation-wide observational study in Taiwan.

作者信息

Lin Yuan, Wu Hsin-Kuan, Wang Te-Hsiung, Chen Tien-Hsing, Lin Yu-Sheng

机构信息

Emergency Medicine Department, Chang Gung Memorial Hospital Keelung Branch, Keelung, Taiwan.

Department of Primary Care and Emergency Medicine, Kyoto University Graduate School of Medicine Faculty of Medicine, Kyoto, Japan.

出版信息

BMJ Open. 2019 May 30;9(5):e023487. doi: 10.1136/bmjopen-2018-023487.

DOI:10.1136/bmjopen-2018-023487
PMID:31152025
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6549656/
Abstract

OBJECTIVES

This study determined the recurrence and complication rates after radiofrequency catheter ablation (RFCA) for those with paroxysmal supraventricular tachycardia (PSVT), Wolff-Parkinson-White syndrome (WPW), atrial flutter (AFL), atrial fibrillation (AF) and ventricular tachycardia (VT).

STUDY DESIGN AND SETTING

This retrospective study included RFCAs for 2001-2010 in the Taiwan National Health Insurance Research Database. Primary outcomes included perioperative complications (pericardial effusion and new-onset stroke), RFCA recurrence and long-term outcomes (high-grade atrioventricular block (AVB) and pacemaker implantation).

RESULTS

Of 19,475 patients who underwent RFCA, prevalence rates were 56.7% for PSVT, 13.5% for WPW, 9.5% for AFL, 5.1% for AF and 2.7% for VT. Prevalence rates increased in AF, AFL and VT over the study years. During an average follow-up period of 4.3 years (SD: 2.8 years), recurrence rates for PSVT, WPW, VT, AFL and AF were 2.0%, 4.9%, 5.7%, 5.8% and 16.1%, respectively. Compared with the PSVT group, the WPW and AF groups had significantly higher risk of pericardial effusion during admission (adjusted OR (aOR) 2.98, 95% CI (CI) 1.24 to 7.15; aOR 4.09, 95% CI 1.90 to 8.79, respectively); the AFL group had a higher risk of new-onset stroke during admission (aOR 4.07, 95% CI 1.39 to 11.91); the WPW group had a lower risk of high-grade AVB during follow-up (adjusted HR (aHR) 0.37, 95% CI 0.19 to 0.71) while the AFL group had a greater risk (aHR 1.74, 95% CI 1.17 to 2.60); and the AFL group had a higher risk of permanent pacemaker (aHR 2.14, 95% CI 1.27 to 3.62).

CONCLUSIONS

The RFCA rate increased rapidly during 2001-2010 for AF, AFL and VT. Recurrence was associated with congenital heart disease in PSVT and WPW, and with age in AF and AFL. AFL had a higher risk of permanent pacemaker implantation and new stroke. AF had a higher risk of life-threatening pericardial effusion.

摘要

目的

本研究确定了阵发性室上性心动过速(PSVT)、预激综合征(WPW)、心房扑动(AFL)、心房颤动(AF)和室性心动过速(VT)患者接受射频导管消融术(RFCA)后的复发率和并发症发生率。

研究设计与背景

这项回顾性研究纳入了台湾国民健康保险研究数据库中2001年至2010年期间的射频导管消融术病例。主要结局包括围手术期并发症(心包积液和新发中风)、射频导管消融术复发率和长期结局(高度房室传导阻滞(AVB)和起搏器植入)。

结果

在19475例行射频导管消融术的患者中,PSVT的患病率为56.7%,WPW为13.5%,AFL为9.5%,AF为5.1%,VT为2.7%。在研究期间,AF、AFL和VT的患病率有所上升。在平均4.3年(标准差:2.8年)的随访期内,PSVT、WPW、VT、AFL和AF的复发率分别为2.0%、4.9%、5.7%、5.8%和16.1%。与PSVT组相比,WPW组和AF组入院期间心包积液风险显著更高(校正比值比(aOR)分别为2.98,95%可信区间(CI)为1.24至7.15;aOR为4.09,95%CI为1.90至8.79);AFL组入院期间新发中风风险更高(aOR为4.07,95%CI为1.39至11.91);WPW组随访期间高度AVB风险较低(校正风险比(aHR)为0.37,95%CI为0.19至0.71),而AFL组风险更高(aHR为1.74,95%CI为1.17至2.60);AFL组永久起搏器风险更高(aHR为2.14,95%CI为1.27至3.62)。

结论

2001年至2010年期间,AF、AFL和VT的射频导管消融术发生率迅速上升。PSVT和WPW的复发与先天性心脏病有关,AF和AFL的复发与年龄有关。AFL永久起搏器植入和新发中风风险更高。AF危及生命的心包积液风险更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad36/6549656/b550792c40a6/bmjopen-2018-023487f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad36/6549656/a3a48cd9b1bf/bmjopen-2018-023487f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad36/6549656/f4bbd0d8b17f/bmjopen-2018-023487f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad36/6549656/b550792c40a6/bmjopen-2018-023487f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad36/6549656/a3a48cd9b1bf/bmjopen-2018-023487f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad36/6549656/f4bbd0d8b17f/bmjopen-2018-023487f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad36/6549656/b550792c40a6/bmjopen-2018-023487f03.jpg

相似文献

1
Trend and risk factors of recurrence and complications after arrhythmias radiofrequency catheter ablation: a nation-wide observational study in Taiwan.心律失常射频导管消融术后复发及并发症的趋势和危险因素:台湾一项全国性观察性研究
BMJ Open. 2019 May 30;9(5):e023487. doi: 10.1136/bmjopen-2018-023487.
2
Radiofrequency catheter ablation for pulmonary hypertension patients with atrial flutter.射频导管消融治疗伴有心房颤动的肺动脉高压患者。
ESC Heart Fail. 2024 Apr;11(2):883-892. doi: 10.1002/ehf2.14659. Epub 2024 Jan 10.
3
Clinical outcomes of catheter ablation for atrial fibrillation, atrial flutter, and atrial tachycardia in wild-type transthyretin amyloid cardiomyopathy: a proposed treatment strategy for catheter ablation in each arrhythmia.野生型转甲状腺素蛋白淀粉样变心肌病中心房颤动、心房扑动和房性心动过速的导管消融的临床转归:每种心律失常导管消融的治疗策略建议。
Europace. 2024 Jun 3;26(6). doi: 10.1093/europace/euae155.
4
Major in-hospital complications after catheter ablation of cardiac arrhythmias: individual case analysis of 43 031 procedures.心脏心律失常导管消融术后主要院内并发症:43031 例病例分析。
Europace. 2023 Dec 28;26(1). doi: 10.1093/europace/euad361.
5
Radiofrequency ablation of accessory pathways in patients with the Wolff-Parkinson-White syndrome: long-term risk of mortality and coronary events.射频消融旁路治疗 Wolff-Parkinson-White 综合征患者:长期死亡率和冠状动脉事件风险。
Europace. 2018 Jun 1;20(6):1035-1042. doi: 10.1093/europace/eux115.
6
Cost Effectiveness Analysis and Payment Policy Recommendation-Population-Based Survey with Big Data Methodology for Readmission Prevention of Patients with Paroxysmal Supraventricular Tachycardia treated with Radiofrequency Catheter Ablation.成本效果分析和支付政策建议——基于大数据方法的阵发性室上性心动过速患者射频导管消融术后再入院预防的人群调查。
Int J Environ Res Public Health. 2020 Mar 30;17(7):2334. doi: 10.3390/ijerph17072334.
7
Electrophysiological characteristics and catheter ablation in patients with paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation.阵发性室上性心动过速和阵发性心房颤动患者的电生理特征及导管消融
J Cardiovasc Electrophysiol. 2008 Apr;19(4):367-73. doi: 10.1111/j.1540-8167.2007.01065.x. Epub 2007 Dec 20.
8
Atrial fibrillation prevalence and atrial vulnerability analysis in paroxysmal supraventricular tachycardia patients after radiofrequency ablation.阵发性室上性心动过速患者射频消融术后房颤患病率及心房易损性分析
Eur Rev Med Pharmacol Sci. 2017 Feb;21(3):584-589.
9
Electrophysiological Characteristics and Outcomes of Radiofrequency Catheter Ablation of Atrial Flutter in Children with or Without Congenital Heart Disease.射频导管消融治疗先天性心脏病或无先天性心脏病儿童房扑的电生理特征和结果。
Pediatr Cardiol. 2020 Oct;41(7):1509-1514. doi: 10.1007/s00246-020-02406-y. Epub 2020 Jul 8.
10
Studies on the prevalence of complicated atrial arrhythmias, flutter, and fibrillation in patients with reciprocating supraventricular tachycardia before and after successful catheter ablation.折返性室上性心动过速患者成功进行导管消融术前和术后复杂性房性心律失常、扑动及颤动患病率的研究
Pacing Clin Electrophysiol. 2001 Jun;24(6):969-78. doi: 10.1046/j.1460-9592.2001.00969.x.

引用本文的文献

1
Efficacy and safety of radiofrequency catheter ablation in younger children with ventricular arrhythmias.射频导管消融术治疗小儿室性心律失常的疗效与安全性
Front Pediatr. 2025 Apr 23;13:1555830. doi: 10.3389/fped.2025.1555830. eCollection 2025.
2
Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children: Insights on its safety and efficacy from a lower middle-income country.射频导管消融治疗儿童阵发性室上性心动过速:来自中低收入国家的安全性和疗效的见解。
Int J Med Sci. 2023 Aug 15;20(10):1293-1299. doi: 10.7150/ijms.86594. eCollection 2023.
3
Hand-held echocardiography during complex electrophysiologic procedures.

本文引用的文献

1
Atrial Flutter, Typical and Atypical: A Review.典型与非典型心房扑动:综述
Arrhythm Electrophysiol Rev. 2017 Jun;6(2):55-62. doi: 10.15420/aer.2017.5.2.
2
Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.非阵发性心房颤动患者消融治疗的疗效与安全性
Cochrane Database Syst Rev. 2016 Nov 22;11(11):CD012088. doi: 10.1002/14651858.CD012088.pub2.
3
Transesophageal echocardiographic screening before atrial flutter ablation: is it necessary for patient safety?经食管超声心动图筛查在心房颤动消融前:对患者安全有必要吗?
复杂电生理手术中的手持式超声心动图检查。
J Cardiovasc Thorac Res. 2023;15(2):80-85. doi: 10.34172/jcvtr.2023.31621. Epub 2023 Jun 29.
4
Freedom from atrial arrhythmia and other clinical outcomes at 5 years and beyond after catheter ablation of atrial fibrillation: a systematic review and meta-analysis.导管消融心房颤动 5 年及以上后无房性心律失常和其他临床结局:系统评价和荟萃分析。
Eur Heart J Qual Care Clin Outcomes. 2023 Aug 7;9(5):447-458. doi: 10.1093/ehjqcco/qcad037.
5
The success rate of radiofrequency catheter ablation in Wolff-Parkinson-White-Syndrome patients: A systematic review and meta-analysis.射频导管消融术治疗 Wolff-Parkinson-White 综合征患者的成功率:系统评价和荟萃分析。
Indian Heart J. 2023 Mar-Apr;75(2):98-107. doi: 10.1016/j.ihj.2023.02.001. Epub 2023 Feb 8.
6
Outcome of catheter ablation in the very elderly-insights from a large matched analysis.高龄患者导管消融治疗的结果——来自一项大型配对分析的见解。
Clin Cardiol. 2020 Dec;43(12):1423-1427. doi: 10.1002/clc.23455. Epub 2020 Aug 31.
7
Cost Effectiveness Analysis and Payment Policy Recommendation-Population-Based Survey with Big Data Methodology for Readmission Prevention of Patients with Paroxysmal Supraventricular Tachycardia treated with Radiofrequency Catheter Ablation.成本效果分析和支付政策建议——基于大数据方法的阵发性室上性心动过速患者射频导管消融术后再入院预防的人群调查。
Int J Environ Res Public Health. 2020 Mar 30;17(7):2334. doi: 10.3390/ijerph17072334.
J Am Soc Echocardiogr. 2013 Sep;26(9):1099-105. doi: 10.1016/j.echo.2013.05.017. Epub 2013 Jul 11.
4
Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.核苷类似物与肝切除术后乙型肝炎病毒相关肝细胞癌复发的风险之间的关联。
JAMA. 2012 Nov 14;308(18):1906-14. doi: 10.1001/2012.jama.11975.
5
Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left ventricular systolic function.经导管心房颤动消融治疗左心室收缩功能障碍患者的长期疗效。
J Cardiovasc Electrophysiol. 2013 Jan;24(1):24-32. doi: 10.1111/j.1540-8167.2012.02419.x. Epub 2012 Nov 9.
6
Mechanisms of arrhythmias and conduction disorders in older adults.老年人心律失常和传导障碍的机制。
Clin Geriatr Med. 2012 Nov;28(4):555-73. doi: 10.1016/j.cger.2012.08.005.
7
Radiofrequency ablation for atrial tachycardia and atrial flutter.射频消融治疗房性心动过速和心房扑动。
Heart Lung Circ. 2012 Jun;21(6-7):386-94. doi: 10.1016/j.hlc.2012.02.001. Epub 2012 Mar 29.
8
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.2012年心房颤动导管消融与外科消融专家共识声明:患者选择、手术技术、患者管理与随访、定义、终点及研究试验设计的推荐意见
J Interv Card Electrophysiol. 2012 Mar;33(2):171-257. doi: 10.1007/s10840-012-9672-7.
9
Radiofrequency ablation of cardiac arrhythmias: past, present and future.射频消融治疗心律失常:过去、现在和未来。
QJM. 2012 Apr;105(4):303-14. doi: 10.1093/qjmed/hcr189. Epub 2011 Nov 12.
10
Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias.当代导管消融治疗心律失常的主要并发症的发生率及预测因素。
Heart Rhythm. 2011 Nov;8(11):1661-6. doi: 10.1016/j.hrthm.2011.05.017. Epub 2011 May 27.